- Home
- MRVI vs IRMD Comparison
MRVI vs IRMD Comparison
Compare MRVI & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- IRMD
- Stock Information
- Founded
- MRVI 2020
- IRMD 1992
- Country
- MRVI United States
- IRMD United States
- Employees
- MRVI N/A
- IRMD N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- IRMD Medical/Dental Instruments
- Sector
- MRVI Health Care
- IRMD Health Care
- Exchange
- MRVI Nasdaq
- IRMD Nasdaq
- Market Cap
- MRVI 795.7M
- IRMD 712.8M
- IPO Year
- MRVI 2020
- IRMD 2014
- Fundamental
- Price
- MRVI $4.11
- IRMD $56.24
- Analyst Decision
- MRVI Buy
- IRMD Strong Buy
- Analyst Count
- MRVI 10
- IRMD 1
- Target Price
- MRVI $10.28
- IRMD $72.00
- AVG Volume (30 Days)
- MRVI 2.4M
- IRMD 44.8K
- Earning Date
- MRVI 02-25-2025
- IRMD 02-13-2025
- Dividend Yield
- MRVI N/A
- IRMD 1.21%
- EPS Growth
- MRVI N/A
- IRMD 11.11
- EPS
- MRVI N/A
- IRMD 1.50
- Revenue
- MRVI $276,920,000.00
- IRMD $73,242,121.00
- Revenue This Year
- MRVI N/A
- IRMD $10.58
- Revenue Next Year
- MRVI $1.93
- IRMD $17.74
- P/E Ratio
- MRVI N/A
- IRMD $37.49
- Revenue Growth
- MRVI N/A
- IRMD 11.71
- 52 Week Low
- MRVI $3.93
- IRMD $40.18
- 52 Week High
- MRVI $11.56
- IRMD $63.29
- Technical
- Relative Strength Index (RSI)
- MRVI 35.37
- IRMD 42.50
- Support Level
- MRVI $4.05
- IRMD $49.56
- Resistance Level
- MRVI $4.40
- IRMD $61.59
- Average True Range (ATR)
- MRVI 0.31
- IRMD 2.27
- MACD
- MRVI -0.05
- IRMD -0.63
- Stochastic Oscillator
- MRVI 15.38
- IRMD 48.65
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About IRMD iRadimed Corporation
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.